theMednetRegister

Primary Care

Prostate Cancer   

Questions discussed in this category

How do you manage dry eye related to Pluvicto Lu-177?
2 Answers available
Do you have recommendations after prostate RT for patients who want to conceive?
Patients in their later 40s with favorable intermediate-risk prostate cancer s/p 7000cGy/28 EBRT only.
1 Answer available
Do you change your monitoring strategy for a high risk prostate cancer after XRT if the initial PSAs have never been very high?
4 Answers available
In asymptomatic patients with unfavorable intermediate risk prostate cancer and a PSA <10, how helpful/reliable and clinically useful is bone imaging?
2 Answers available
Do you recommend a waiting period to conceive after prostate radiation?
1 Answer available
What can prostate patients do for sexual function while on ADT?
4 Answers available
For what patient groups (if any) do you routinely recommend screening colonoscopy prior to radiation for prostate cancer?
3 Answers available
How do you manage musculoskeletal pain in men receiving androgen deprivation therapy for non-metastatic prostate cancer?
In patients with new bone pain and without any evidence of bone metastases receiving GnRH agonists, how do you manage pain symptoms?
1 Answer available
Do you counsel patients on the risk of dementia following androgen deprivation therapy for prostate cancer?
Two retrospective studies from Stanford showed that patients who received ADT had an increased risk of dementia and Alzheimer's. Is this finding ...
3 Answers available
For patients eligible for and considering active surveillance for low-risk prostate cancer, do you routinely use tests for molecular risk stratification?
Are there specific subsets for whom these results should change management?
1 Answer available
At what PSA do you start calculating doubling time post-prostatectomy?
With ultra-sensitive PSA, it's unclear to me whether a doubling from 0.01 to 0.02 or 0.02 to 0.04 is significant. Is there a certain value that you wo...
1 Answer available
Which patients with intermediate and high risk prostate cancer should not receive androgen deprivation therapy?
More specifically, which cardiac risk factors do you look for? Diabetes? Previous MI? Dyslipidemia? Peripheral vascular disease? CHF?
2 Answers available


Papers discussed in this category

European urology, 2013-12
A new risk classification system for therapeutic decision making with intermediate-risk prostate cancer patients undergoing dose-escalated external-beam radiation therapy.
CA Cancer J Clin, 2010 May-Jun
Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation Oncology.
J Natl Cancer Inst, 2010 Jan 6
Diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostate cancer.
BJU international, 2014-12
The impact of androgen-deprivation therapy (ADT) on the risk of cardiovascular (CV) events in patients with non-metastatic prostate cancer: a population-based study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015-06-20
Course and Predictors of Cognitive Function in Patients With Prostate Cancer Receiving Androgen-Deprivation Therapy: A Controlled Comparison.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016-02-20
Androgen Deprivation Therapy and Future Alzheimer's Disease Risk.
JAMA oncology, 2016-04
Adverse Health Events Following Intermittent and Continuous Androgen Deprivation in Patients With Metastatic Prostate Cancer.
JAMA oncology, 2017-01-01
Association Between Androgen Deprivation Therapy and Risk of Dementia.
International journal of radiation oncology, biology, physics, 2010-06-01
Incidental testicular irradiation from prostate IMRT: it all adds up.
International journal of radiation oncology, biology, physics, 2012-01-01
Testicular doses in image-guided radiotherapy of prostate cancer.
Adv Urol, 2011 Oct 16
Modern Detection of Prostate Cancer's Bone Metastasis: Is the Bone Scan Era Over?
Eur Urol, 2009 Dec 18
When to perform bone scan in patients with newly diagnosed prostate cancer: external validation of the currently available guidelines and proposal of a novel risk stratification tool.
Scandinavian journal of urology and nephrology, 2004
Does brachytherapy of the prostate affect sperm quality and/or fertility in younger men?
BJU international, 2005-10
New life after prostate brachytherapy? Considering the fertile female partner of the brachytherapy patient.
Andrologia, 2017-02
Successful sperm extraction and live birth after radiation, androgen deprivation and surgical castration for treatment of metastatic prostate cancer.
Current opinion in urology, 2007 Nov
Therapeutic testis biopsy for sperm retrieval.
N Engl J Med, 2021 Jun 23
Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer.

Related Topics in Primary Care

Copyright © 2025 theMednet
All Rights Reserved.